Zevra Therapeutics, Inc.
ZVRA
$7.99
-$0.225-2.74%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 311.33% | 18.81% | 2.60% | 7.13% | -43.62% |
Total Receivables | 104.16% | 51.92% | -39.52% | -85.00% | -36.24% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 62.03% | 101.61% | 122.15% | 37.03% | 32.77% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 271.71% | 29.71% | -1.05% | -27.42% | -41.13% |
|
|||||
Total Current Assets | 271.71% | 29.71% | -1.05% | -27.42% | -41.13% |
Net Property, Plant & Equipment | 31.84% | 15.55% | -33.62% | 6.49% | 6.50% |
Long-term Investments | 0.00% | 0.00% | 0.00% | -- | -- |
Goodwill | 0.00% | 0.00% | 0.00% | -- | -- |
Total Other Intangibles | -89.34% | -0.48% | -0.34% | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -90.95% | -23.25% | 14.57% | 1,373.45% | 1,748.58% |
Total Assets | 77.47% | 14.16% | 3.37% | 37.82% | 36.86% |
|
|||||
Total Accounts Payable | -22.54% | -21.80% | -6.52% | 105.93% | 94.60% |
Total Accrued Expenses | -17.27% | 16.06% | -8.42% | -5.97% | -2.83% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -11.91% | 1.03% | -22.65% | 24.14% | 29.85% |
Total Finance Division Other Current Liabilities | 160.77% | 62.81% | 26.78% | 200.97% | 727.99% |
Total Other Current Liabilities | 160.77% | 62.81% | 26.78% | 200.97% | 727.99% |
Total Current Liabilities | -5.31% | -9.81% | -53.79% | 58.80% | 66.83% |
|
|||||
Total Current Liabilities | -5.31% | -9.81% | -53.79% | 58.80% | 66.83% |
Long-Term Debt | 4.05% | 39.75% | 1,074.58% | 34.26% | 358.95% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 94.67% | 64.26% | -18.42% | -6.58% | -13.24% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 114.36% | 50.63% | 42.60% | 416.24% | 316.30% |
Total Liabilities | 24.23% | 28.52% | 25.35% | 70.29% | 202.36% |
|
|||||
Common Stock & APIC | 17.72% | 17.73% | 17.48% | 31.63% | 18.32% |
Retained Earnings | 0.61% | -22.09% | -26.39% | -38.32% | -34.08% |
Treasury Stock & Other | -26.97% | -2.06% | 6.11% | 0.94% | 5.76% |
Total Common Equity | 260.95% | -15.97% | -35.88% | 3.41% | -52.59% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 260.95% | -15.97% | -35.88% | 3.41% | -52.59% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 260.95% | -15.97% | -35.88% | 3.41% | -52.59% |
|